Featured

Bristol-Myers Squibb Co

Here’s Why Bristol-Myers Squibb Was So Kind To Nektar In The...

Bristol-Myers Squibb Company (NYSE:BMY) and Nektar Therapeutics (NASDAQ:NKTR) are drawing a considerable amount of attention in the biotechnology space this week, on the back...

Market Exclusive Biotech News & Analysis

Bristol-Myers Squibb Co

Here’s Why Bristol-Myers Squibb Was So Kind To Nektar In The...

Bristol-Myers Squibb Company (NYSE:BMY) and Nektar Therapeutics (NASDAQ:NKTR) are drawing a considerable amount of attention in the biotechnology space this week, on the back...

Here’s What’s Moving Tetraphase

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) didn't have a great start to the week this week. The company just put out data from a phase 3...